Efficacy of Imidazole Antifungal Agents in the Treatment of Nras and Braf Mutant Human Melanoma Cells

被引：0
|
作者：
Koh, David [1 ]
Jira, Lukas R. [1 ]
Foster, Hattie M. [1 ]
Carle, McKenzie N. [1 ]
Hall, Hannah K. [1 ]
Sutherland, Maxwell A. [1 ]
机构：
[1] Ohio Northern Univ, Coll Pharm, Ada, OH USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.196240
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
241
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Biology and treatment of BRAF mutant metastatic melanoma
    Kong, Benjamin Y.
    Carlino, Matteo S.
    Menzies, Alexander M.
    MELANOMA MANAGEMENT, 2016, 3 (01) : 33 - 45
  • [22] Vemurafenib for the treatment of BRAF mutant metastatic melanoma
    Martin-Liberal, Juan
    Larkin, James
    FUTURE ONCOLOGY, 2015, 11 (04) : 579 - 589
  • [23] Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma
    Akil, Hussein
    Quintana, Mercedes
    Raymond, Jeremy H.
    Billoux, Tommy
    Benboubker, Valentin
    Besse, Sophie
    Auzeloux, Philippe
    Delmas, Veronique
    Petit, Valerie
    Larue, Lionel
    D'Incan, Michel
    Degoul, Francoise
    Rouanet, Jacques
    CANCERS, 2021, 13 (06) : 1 - 20
  • [24] BRAF, NRAS, HRAS genes profile in human melanoma cell lines
    Czajkowski, Rafal
    Placek, Waldemar
    Tadrowski, Tadeusz
    Pokrywczynska, Marta
    Zegarska, Barbara
    Drewa, Tomasz
    PRZEGLAD DERMATOLOGICZNY, 2009, 96 (04): : 265 - 270
  • [25] Unveiling the metabolic response of BRAF mutant melanoma cells to BRAF inhibition
    Delgado-Goni, Teresa
    Wantuch, Slawomir
    Workman, Paul
    Marais, Richard
    Leach, Martin
    Beloueche-Babari, Mounia
    CANCER RESEARCH, 2015, 75
  • [26] Regulating the response to targeted MEK inhibition in melanoma Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation
    Conrad, William H.
    Swift, Reyna D.
    Biechele, Travis L.
    Kulikauskas, Rima M.
    Moon, Randall T.
    Chien, Andy J.
    CELL CYCLE, 2012, 11 (20) : 3724 - 3730
  • [27] Targeting different conformations of BRAF kinase: efficacy of Omni-Raf inhibitors in NRAS and BRAF mutant tumors
    Zhang, C.
    Cho, H.
    Spevak, W.
    Zhang, Y.
    Burton, B.
    Wong, B.
    Tsai, J.
    Ibrahim, P.
    Hirth, P.
    Bollag, G.
    EJC SUPPLEMENTS, 2010, 8 (07): : 46 - 46
  • [28] ARAF mutations confer resistance to RAF dimer inhibitors in NRAS and BRAF mutant melanoma.
    Malek, Shiva
    CANCER RESEARCH, 2021, 81 (13)
  • [29] Current Advances in the Treatment of BRAF-Mutant Melanoma
    Patel, Hima
    Yacoub, Nour
    Mishra, Rosalin
    White, Aaron
    Yuan, Long
    Alanazi, Samar
    Garrett, Joan T.
    CANCERS, 2020, 12 (02)
  • [30] Efficacy of triple combination treatment with trametinib, mebendazole and CD133 RNA aptamer in recalcitrant NRAS-mutant melanoma cells
    Haribabu, Yoga
    Chien, Raymond
    Alobaidi, Ryyan
    Kuo, Li-Wei
    Islam, Nusrat
    Simbulan-Rosenthal, Cynthia M.
    Rosenthal, Dean S.
    CANCER RESEARCH, 2022, 82 (12)
12345